427 related articles for article (PubMed ID: 34623131)
1. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems.
Cai P; Zheng Y; Sun Y; Zhang C; Zhang Q; Liu Q
ACS Chem Neurosci; 2021 Oct; 12(20):3829-3837. PubMed ID: 34623131
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
[TBL] [Abstract][Full Text] [Related]
3. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
4. An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.
Patabendige A
Methods Mol Biol; 2022; 2492():131-142. PubMed ID: 35733042
[TBL] [Abstract][Full Text] [Related]
5. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
6. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
7. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells.
Nakagawa S; Deli MA; Nakao S; Honda M; Hayashi K; Nakaoke R; Kataoka Y; Niwa M
Cell Mol Neurobiol; 2007 Sep; 27(6):687-94. PubMed ID: 17823866
[TBL] [Abstract][Full Text] [Related]
8. Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting.
Smith M; Omidi Y; Gumbleton M
J Drug Target; 2007 May; 15(4):253-68. PubMed ID: 17487694
[TBL] [Abstract][Full Text] [Related]
9. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T
Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the rate of dedifferentiation with increasing passages among cell sources for an in vitro model of the blood-brain barrier.
Fujimoto T; Morofuji Y; Nakagawa S; Kovac A; Horie N; Izumo T; Niwa M; Matsuo T; Banks WA
J Neural Transm (Vienna); 2020 Aug; 127(8):1117-1124. PubMed ID: 32382826
[TBL] [Abstract][Full Text] [Related]
11. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.
Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T
Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240
[TBL] [Abstract][Full Text] [Related]
12. Communication from the periphery to the hypothalamus through the blood-brain barrier: An in vitro platform.
Martins JP; Alves CJ; Neto E; Lamghari M
Int J Pharm; 2016 Feb; 499(1-2):119-130. PubMed ID: 26732523
[TBL] [Abstract][Full Text] [Related]
13. Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport.
Molino Y; Jabès F; Lacassagne E; Gaudin N; Khrestchatisky M
J Vis Exp; 2014 Jun; (88):e51278. PubMed ID: 24998179
[TBL] [Abstract][Full Text] [Related]
14. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies.
Li G; Simon MJ; Cancel LM; Shi ZD; Ji X; Tarbell JM; Morrison B; Fu BM
Ann Biomed Eng; 2010 Aug; 38(8):2499-511. PubMed ID: 20361260
[TBL] [Abstract][Full Text] [Related]
15. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
Lu W; Tan YZ; Jiang XG
Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
17. The pivotal role of micro-environmental cells in a human blood-brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis.
Gerhartl A; Pracser N; Vladetic A; Hendrikx S; Friedl HP; Neuhaus W
Fluids Barriers CNS; 2020 Mar; 17(1):19. PubMed ID: 32138745
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System.
Qi D; Wu S; Lin H; Kuss MA; Lei Y; Krasnoslobodtsev A; Ahmed S; Zhang C; Kim HJ; Jiang P; Duan B
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21825-21835. PubMed ID: 29897225
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Influence of Astrocytes on
García-Salvador A; Domínguez-Monedero A; Gómez-Fernández P; García-Bilbao A; Carregal-Romero S; Castilla J; Goñi-de-Cerio F
Altern Lab Anim; 2020 Jul; 48(4):184-200. PubMed ID: 33136430
[No Abstract] [Full Text] [Related]
20. In vitro models of the blood-brain barrier.
Czupalla CJ; Liebner S; Devraj K
Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
